FDA finds control lapses at Catalent plant being sold to Novo

[cafead]

via U.S. drug regulators in November found quality control lapses at the Bloomington, Indiana factory of contract drug manufacturer Catalent (CTLT.N), opens new tab, including discovery of a "pest" on the manufacturing line, according to an inspection report.

article source